Oxybutynin MR (Lyrinel XL)
It is not acceptable for short-term use prior to bladder
surgery. Only the sustained-release formulation is permitted.
Tolterodine MR (Detrusitol XL)
Trospium IR and MR (Regurin)
Side-effects to enquire about are mainly anti-cholinergic
such as dry mouth, blurred vision and drowsiness. If these do not occur in the
first few months they are extremely unlikely to occur later.
Unfit for a minimum of four weeks or until a stable dose is
achieved with adequate symptom control.
OML for at least four months.
If the dose of drug remains stable with satisfactory symptom
control and no reported side-effects, then unrestricted certification can be
considered at four months. Any change in dosage should entail a grounding
period of four weeks followed by reassessment. Pilots should be advised to keep
themselves hydrated before and during flights.
Unfit for a minimum of four weeks or until a stable dose to
achieve with adequate symptom control. If the dose of drug remains stable with
satisfactory symptom control and no reported side-effects, then unrestricted
certification can be considered at four weeks. Any change in dosage should
entail a grounding period of four weeks, followed by reassessment.
Read all @UK_CAA
Stay in Control: CAA launches loss of control awareness campaign
7 July, 2020
Singapore and the United Kingdom commence trials to improve public health safety for air crew
6 July, 2020
UK Civil Aviation Authority update on airline refunds review
1 July, 2020
Read all News
How safe is recreational flying in the UK
25 February, 2020
Our unmanned aircraft systems unit
5 June, 2019
Inspecting commercial drone operators
29 March, 2019
Read All Blogs